Overview
Lobbying Costs
150,000€
Financial year: Jan 2019 - Dec 2019
Lobbyists (Full time equivalent)
1.25 Fte (4)
Lobbyists with EP accreditation
0
High-level Commission meetings
3
Lobbying Costs over the years
-
Info
Centrient Pharmaceuticals
EU Transparency Register
494574538937-86 First registered on 13 Jul 2020
Goals / Remit
Centrient Pharmaceuticals is the global business-to-business leader in sustainable, enzymatic antibiotics, next-generation statins and anti-fungals. We produce and sell intermediates and active pharmaceutical ingredients (APIs), as well as our own tablets, capsules and other finished dosage forms (FDFs).
We are a pharmaceutical company with a mission to improve lives by being at the centre of sustainable and accessible healthcare.Main EU files targeted
EU Pharmaceutical Strategy, EU Healthcare Policy, EU Industrial Policy, EU Environmental Policy (Green Deal), EU Trade Policy, AMR Policy
Address
Head Office
Weena 798A
Rotterdam 3014DA
NETHERLANDS -
People
Total lobbyists declared
4
Employment time Lobbyists 50% 1 25% 3 Lobbyists (Full time equivalent)
1.25
Lobbyists with EP accreditation
No lobbyists with EP accreditations
Complementary Information
None declared
Person in charge of EU relations
Data not provided by Register Secretariat due to GDPR
Person with legal responsibility
Data not provided by Register Secretariat due to GDPR
-
Categories
Category
II - In-house lobbyists and trade/business/professional associations
Subcategory
Companies & groups
-
Networking
Affiliation
Medicines for Europe, CEFIC, AMR Industry Alliance
Member organisations
Medicines for Europe, CEFIC, AMR Industry Alliance
-
Financial Data
Closed financial year
Jan 2019 - Dec 2019
Lobbying costs for closed financial year
150,000€
Other financial info
None declared
-
EU Structures
Groups (European Commission)
none
Groups (European Parliament)
N/A
Communication activities
None
Other activities
None declared
Meetings
Meetings
3 meetings found. Download meetings
The list below only covers meetings held since November 2014 with commissioners, their cabinet members or directors-general at the European Commission; other lobby meetings with lower-level staff may have taken place, but the European Commission doesn't proactively publish information about these meetings. For more information about which commissioner is responsible for which portfolio, check out this link: https://commissioners.ec.europa.eu/index_en All information below comes from European Commission web pages.
-
Date 30 Jun 2022 Location Santa Perpètua de Mogoda Subject Pharmaceutical Strategy Cabinet Cabinet of Vice-President Margaritis Schinas Portfolio Promoting the European Way of Life Attending - Maria Luisa Llano Cardenal (Cabinet member)
- Margaritis Schinas (Vice-President)
-
Date 14 Jan 2022 Location Videoconference Subject Security of supply of pharmaceutical ingredients and intermediates Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Maurits-Jan Prinz (Cabinet member)
-
Date 15 Sep 2020 Location Videoconference Subject Strengthening the EU’s production capacity for live-saving pharmaceuticals. Cabinet Cabinet of Commissioner Thierry Breton Portfolio Internal Market Attending - Eszter Batta (Cabinet member)